JNJ

192.06

-0.32%↓

ABT

126.47

-1.09%↓

MDT

94.35

-1.76%↓

VEEV

291.35

+0.66%↑

A

147.16

+0.91%↑

JNJ

192.06

-0.32%↓

ABT

126.47

-1.09%↓

MDT

94.35

-1.76%↓

VEEV

291.35

+0.66%↑

A

147.16

+0.91%↑

JNJ

192.06

-0.32%↓

ABT

126.47

-1.09%↓

MDT

94.35

-1.76%↓

VEEV

291.35

+0.66%↑

A

147.16

+0.91%↑

JNJ

192.06

-0.32%↓

ABT

126.47

-1.09%↓

MDT

94.35

-1.76%↓

VEEV

291.35

+0.66%↑

A

147.16

+0.91%↑

JNJ

192.06

-0.32%↓

ABT

126.47

-1.09%↓

MDT

94.35

-1.76%↓

VEEV

291.35

+0.66%↑

A

147.16

+0.91%↑

Search

Simulations Plus Inc

Geschlossen

BrancheGesundheitswesen

17.15 -2.5

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

17.15

Max

18.24

Schlüsselkennzahlen

By Trading Economics

Einkommen

-70M

-67M

Verkäufe

-2.1M

20M

KGV

Branchendurchschnitt

48.528

37.461

Dividendenrendite

0.48

Gewinnspanne

-330.585

Angestellte

243

EBITDA

-79M

-74M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

-9.19% downside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.48%

2.33%

Nächstes Ergebnis

29. Okt. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-28M

323M

Vorheriger Eröffnungskurs

19.65

Vorheriger Schlusskurs

17.15

Nachrichtenstimmung

By Acuity

38%

62%

133 / 371 Ranking in Healthcare

Simulations Plus Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

22. Okt. 2025, 22:47 UTC

Akquisitionen, Fusionen, Übernahmen

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project -- Update

22. Okt. 2025, 22:13 UTC

Akquisitionen, Fusionen, Übernahmen

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project

22. Okt. 2025, 21:20 UTC

Ergebnisse

Correction to IBM 3Q Sales Jump Article

22. Okt. 2025, 20:57 UTC

Ergebnisse

SAP Posts Higher 3Q Revenue, Operating Profit

22. Okt. 2025, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22. Okt. 2025, 23:46 UTC

Market Talk

Nikkei May Decline Amid U.S.-China Trade Tensions -- Market Talk

22. Okt. 2025, 23:41 UTC

Market Talk

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

22. Okt. 2025, 23:38 UTC

Market Talk

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

22. Okt. 2025, 23:15 UTC

Ergebnisse

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 4th Update

22. Okt. 2025, 22:28 UTC

Market Talk

Alcoa Cautions About Spending More on U.S. Smelters -- Market Talk

22. Okt. 2025, 22:02 UTC

Ergebnisse

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 3rd Update

22. Okt. 2025, 21:59 UTC

Akquisitionen, Fusionen, Übernahmen

Williams Cos.: Entered Into 1.5 Mtpa LNG Offtake Obligation >WMB

22. Okt. 2025, 21:58 UTC

Akquisitionen, Fusionen, Übernahmen

Williams Cos. to Buy 10% Interest in Louisiana LNG LLC >WMB

22. Okt. 2025, 21:57 UTC

Akquisitionen, Fusionen, Übernahmen

Williams Cos. to Buy 80% Ownership In, Become Operator of Driftwood Pipeline >WMB

22. Okt. 2025, 21:56 UTC

Akquisitionen, Fusionen, Übernahmen

Williams Cos.: Strategic Partnership Entered With Woodside Energy to Invest in Louisiana LNG Project >WMB

22. Okt. 2025, 21:47 UTC

Akquisitionen, Fusionen, Übernahmen

Woodside: Williams to Assume LNG Offtake Obligations for 10% of Produced Volumes

22. Okt. 2025, 21:47 UTC

Ergebnisse

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

22. Okt. 2025, 21:47 UTC

Akquisitionen, Fusionen, Übernahmen

Woodside: Williams to Contribute Its Share of Capex for LNG Facility, Pipeline

22. Okt. 2025, 21:46 UTC

Akquisitionen, Fusionen, Übernahmen

Woodside Energy Says Williams Deals Worth US$378 Million Including Capital Reimbursement

22. Okt. 2025, 21:45 UTC

Akquisitionen, Fusionen, Übernahmen

Woodside Energy to Sell 80% Interest in Driftwood Pipeline Co. to Williams

22. Okt. 2025, 21:45 UTC

Akquisitionen, Fusionen, Übernahmen

Woodside Energy to Sell 10% Interest in Louisiana LNG Holding Co. to Williams

22. Okt. 2025, 21:28 UTC

Market Talk
Ergebnisse

Correction to Alcoa Tariff Market Talk

22. Okt. 2025, 21:25 UTC

Ergebnisse

Wall Street Wonders if Grail's Cancer Test Results Are a True Positive -- Barrons.com

22. Okt. 2025, 21:17 UTC

Ergebnisse

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 2nd Update

22. Okt. 2025, 21:09 UTC

Market Talk
Ergebnisse

Alcoa Says Delivery Fee Covering Tariff Costs -- Market Talk

22. Okt. 2025, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

22. Okt. 2025, 20:59 UTC

Ergebnisse

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

22. Okt. 2025, 20:51 UTC

Ergebnisse

SAP Reports Mixed Earnings. The Stock is Down. -- Barrons.com

22. Okt. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22. Okt. 2025, 20:44 UTC

Ergebnisse

Kaiser Aluminum: For the Full Yr 2025, Now Expects Conversion Rev to Be Flat to Up 5% Yr-Over-Yr and Raises Adjusted EBITDA Outlook to Improve 20% to 25% Yr-Over-Yr >KALU

Peer-Vergleich

Kursveränderung

Simulations Plus Inc Prognose

Kursziel

By TipRanks

-9.19% Nachteil

12-Monats-Prognose

Durchschnitt 16 USD  -9.19%

Hoch 16 USD

Tief 16 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Simulations Plus Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

3 ratings

2

Buy

1

Halten

0

Sell

Stimmung

By Acuity

133 / 371 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat